Lithium chloride suppresses LPS-mediated matrix metalloproteinase-9 expression in macrophages through phosphorylation

Sooho Kim1, Naeun Bong, Ok Soo Kim

  • 1Laboratory of Genome to Drug Medicine, Joint Center for Biosciences, 7-45 Songdo-dong, Yeonsu-ku, Incheon, Korea.

Insights

Lithium chloride (LiCl) and CHIR99021 suppress matrix metalloproteinase-9 (MMP-9) in macrophages by altering histone deacetylase activity. This finding may explain LiCl

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Matrix metalloproteinase-9 (MMP-9) dysregulation in macrophages contributes to acute cerebral ischemia and atherosclerosis progression.
  • Understanding MMP-9 regulation is crucial for developing therapeutic strategies against these conditions.

Purpose of the Study:

  • To investigate the effects of Wnt signaling inhibitors on MMP-9 expression in macrophages.
  • To elucidate the molecular mechanisms underlying MMP-9 suppression by lithium chloride (LiCl) and CHIR99021.

Main Methods:

  • Utilized murine macrophage RAW264.7 cells.
  • Administered LiCl and CHIR99021, Wnt signaling pathway inhibitors.
  • Assessed lipopolysaccharide-mediated MMP-9 expression.
  • Investigated the role of glycogen synthase kinase-3beta phosphorylation, NFκB, AP-1, and histone deacetylase activity.

Main Results:

  • LiCl and CHIR99021 dose-dependently enhanced glycogen synthase kinase-3beta phosphorylation.
  • These inhibitors suppressed lipopolysaccharide-induced upregulation of MMP-9 expression.
  • MMP-9 suppression was linked to changes in histone deacetylase activity, not NFκB or AP-1 pathways.

Conclusions:

  • Wnt signaling inhibition, via LiCl or CHIR99021, effectively suppresses MMP-9 expression in macrophages.
  • The mechanism involves histone deacetylase modulation.
  • These findings provide a molecular basis for the beneficial effects of LiCl in animal models of atherosclerosis and cerebral ischemia.

Related Concept Videos